Abcellera Biologics Inc (ABCL)

Überblick Nachrichten Preisverlauf Optionskette Financials Warum fällt ABCL? Forum Prognose

Finanzdaten der Abcellera Biologics Inc-Aktie (ABCL)

*Alle Zahlen in Millionen

Enddatum des Zeitraums	2024-03-31	2023-12-31	2023-09-30	2023-06-30	2023-03-31
Periodenlänge	3 Monate	3 Monate	3 Monate	3 Monate	3 Monate
Revenues	8.44% 9.954	9.179	6.599	10.06	12.19
Operating Expenses	13.80% 64.85	75.23	61.49	61.45	77.07
Benefits Costs and Expenses	8.79% 52.70	57.78	45.88	48.06	60.34
Costs And Expenses	8.79% 52.70	57.78	45.88	48.06	60.34
Depreciation and Amortization	35.72% 4.844	7.536	5.735	5.61	5.514
Operating Income/Loss	16.89% -54.89	-66.05	-54.89	-51.39	-64.87
Nonoperating Income/Loss	30.39% 12.15	17.45	15.61	13.38	16.73
Income/Loss From Continuing Operations Before Tax	12.05% -42.75	-48.60	-39.28	-38.00	-48.15
Income Tax Expense/Benefit	47.18% -2.137	-1.452	-10.67	-7.476	-8.038
Income/Loss From Continuing Operations After Tax	13.87% -40.61	-47.15	-28.61	-30.53	-40.11
Net Income/Loss	13.87% -40.61	-47.15	-28.61	-30.53	-40.11
Preferred Stock Dividends And Other Adjustments	-	-	-	-	-
Attributable To Noncontrolling Interest	-	-	-	-	-
Basic Average Shares	70,250% 292.72	0.4161	289.50	288.91	287.77
Diluted Average Shares	70,250% 292.72	0.4161	289.50	288.91	287.77
Basic Earnings Per Share	17.65% -0.14	-0.17	-0.10	-0.11	-0.14
Diluted Earnings Per Share	17.65% -0.14	-0.17	-0.10	-0.11	-0.14
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic	-	-	-	-	-

SMMT

$18.98

3.66%

INCY

$76.97

1.45%

MRNA

$39.51

7.22%

UTHR

$359.21

1.11%

BGNE

$187.69

0.81%

BNTX

$101.87

2.16%